Pricing Log in Create free account

AbCellera Biologics Inc. (ABCL) vs Legend Biotech Corporation Sponsored ADR (LEGN)

AbCellera Biologics Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. AbCellera Biologics Inc. and Legend Biotech Corporation Sponsored ADR are of similar size ($4.1B and $3.8B). AbCellera Biologics Inc. grew revenue faster over the last twelve months: 101.3% against 59.6%. Legend Biotech Corporation Sponsored ADR has the higher net margin (−7.20% vs −248.8%) and the higher return on invested capital (−9.54% vs −42.5%). Across the 18 metrics below, Legend Biotech Corporation Sponsored ADR leads on 12 and AbCellera Biologics Inc. on 6.

Valuation

Metric ABCL LEGN Biotechnology median
P/E n/m n/m 8.50
P/S 54.49 2.72 9.71
P/B 4.02 2.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 46.00 2.22 9.21
Earnings yield (4.58%) (2.68%) (33.15%)
Free cash flow yield (3.41%) (3.54%) (25.50%)

Profitability

Metric ABCL LEGN Biotechnology median
Gross margin 100.00% 56.58% 65.16%
Operating margin (340.25%) (5.06%) 0.00%
Net margin (248.82%) (7.20%) 0.00%
Free cash flow margin (180.84%) (9.58%) 0.00%
Return on equity (17.30%) (8.08%) (56.36%)
Return on assets (12.15%) (5.32%) (48.04%)
Return on invested capital (42.52%) (9.54%) 0.00%

Growth

Metric ABCL LEGN Biotechnology median
Revenue growth (TTM) 101.29% 59.55% 6.02%
EPS growth (last fiscal year) 10.91% (66.34%) 30.26%
Revenue growth, 5-year CAGR (20.27%) 65.93% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABCL LEGN Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 12.77 3.04 4.72
Net debt to EBITDA 2.97 2.31 0.96

Dividend

Metric ABCL LEGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABCL LEGN Biotechnology median
Market cap 4.11b 3.84b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack